Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06229145
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-01-19
Brief Title:
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks Q4W With MTX Compared With Every 2 Weeks Q2W With MTX in Participants With Uncontrolled Refractory Gout
Sponsor:
Organization:
Amgen